 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral, topical |
| ATC code | |
| Pharmacokinetic data | |
| Eliminationhalf-life | 1 hour |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.004.346 |
| Chemical and physical data | |
| Formula | C28H41N3O3 |
| Molar mass | 467.654 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Oxetacaine (INN, also known asoxethazaine) is a potentlocal anesthetic. It is administered orally (usually in combination with anantacid) for the relief of pain associated withpeptic ulcer disease oresophagitis. It is also used topically in the management ofhemorrhoid pain. Oral oxetacaine preparations are available in several countries, includingIndia,South Africa,Japan,Taiwan andBrazil, but not the United States. Unlike most local anesthetics, oxetacaine does not break down under stronglyacidic conditions.[1]
It is known to producemephentermine andphentermine asmetabolites.[2][3]
 | Thisdrug article relating to thecardiovascular system is astub. You can help Wikipedia byadding missing information. |
 | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byadding missing information. |